Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 6:38 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 145–168 of 238 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Implantable Cardioverter Defibrillator Clear all

Conditions: Bradycardia, Tachycardia, Atrial Fibrillation, Valvular Heart Disease
Interventions: continue warfarin through the procedure, Hold warfarin, Warfarin held with heparin transition.; Drug
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 99 Years
Enrollment: 104 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2010
U.S. locations: 2
States / cities: Baltimore, Maryland • Columbia, Maryland

Conditions: Myocardial Infarction, Sudden Death
Interventions: Implantable Cardioverter Defibrillator + Usual Care, Usual care; Device · Other
Lead sponsor: University of Calgary; Other
Eligibility: 18 Years to 80 Years
Enrollment: 700 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2024
U.S. locations: 29
States / cities: Huntsville, Alabama • Lakewood, Colorado • Tampa, Florida + 23 more

Conditions: Coronary Artery Disease, Left Ventricular Dysfunction, Sudden Cardiac Death
Interventions: Not listed
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years and older
Enrollment: 5,764 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2027
U.S. locations: 86
States / cities: Anchorage, Alaska • Glendale, Arizona • Phoenix, Arizona + 76 more

Conditions: Patients With a Generation 2 Medtronic Implantable Cardioverter-defibrillator(ICD)
Interventions: Not listed
Lead sponsor: Englewood Hospital and Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: Englewood, New Jersey

Conditions: Monomorphic Ventricular Tachycardia
Interventions: Cardiac catheter ablation with ICD/CRT-D; Device
Lead sponsor: Abbott Medical Devices; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 64 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 30
States / cities: Birmingham, Alabama • Los Angeles, California • San Diego, California + 21 more

Conditions: Congestive Heart Failure
Interventions: Not listed
Lead sponsor: Saint Luke's Health System; Other
Eligibility: 18 Years to 90 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 2
States / cities: Elgin, Illinois • Oklahoma City, Oklahoma

Conditions: Heart Failure
Interventions: Not listed
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 18 Years and older
Enrollment: 37 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Arrythmias
Interventions: Not listed
Lead sponsor: National Institute of Environmental Health Sciences (NIEHS); NIH
Eligibility: 0 Years to 90 Years
Enrollment: 500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1998 – 2004
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Ventricular Fibrillation, Ventricular Tachycardia, Low Cardiac Output
Interventions: EMBLEM S-ICD System; Device
Lead sponsor: Boston Scientific Corporation; Industry
Eligibility: 21 Years and older
Enrollment: 1,173 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 69
States / cities: Birmingham, Alabama • Huntsville, Alabama • Gilbert, Arizona + 62 more

Conditions: Ventricular Tachycardia
Interventions: Ventricular Tachycardia Ablation, ICD Implant, Antiarrhythmic drug, EKG, Cardioversion, Echocardiogram; Procedure · Device · Drug + 1 more
Lead sponsor: CorVita Science Foundation; Other
Eligibility: 18 Years and older
Enrollment: 130 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2030
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Heart Failure
Interventions: LMI 1195; Drug
Lead sponsor: Lantheus Medical Imaging; Industry
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: New York, New York

Conditions: Implantable Cardioverter Defibrillators, CRT-D Cardiac Resynchronization Therapy Defibrillator
Interventions: Not listed
Lead sponsor: Boston Scientific Corporation; Industry
Eligibility: Not listed
Enrollment: 1,600 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2021
U.S. locations: 51
States / cities: Birmingham, Alabama • Glendale, Arizona • Tucson, Arizona + 44 more

Conditions: Arrythmia, Cardiac
Interventions: iBeat wristwatch device; Device
Lead sponsor: University of California, San Francisco; Other
Eligibility: 21 Years to 85 Years
Enrollment: 55 participants
Timeline: 2018
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Heart Disease, Cardiovascular Disease, Heart Failure, Arrhythmias, Cardiac
Interventions: Unpaired remote monitoring transmitter; Device
Lead sponsor: Abbott Medical Devices; Industry
Eligibility: 18 Years and older
Enrollment: 99 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Zanesville, Ohio

Conditions: Atrial Fibrillation
Interventions: Internal Cardioversion, External Cardioversion; Procedure
Lead sponsor: University of Kentucky; Other
Eligibility: 18 Years to 99 Years
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Sudden Cardiac Death, Sudden Cardiac Arrest, Heart Failure, Heart Failure Low Output
Interventions: Wearable Cardioverter Defibrillator; Device
Lead sponsor: Zoll Medical Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 602 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2022
U.S. locations: 39
States / cities: Birmingham, Alabama • West Hills, California • Fernandina Beach, Florida + 34 more

Conditions: Tachycardia, Ventricular, Heart Failure, Congestive, Ventricular Fibrillation, Ventricular Dysfunction, Bradycardia
Interventions: Not listed
Lead sponsor: Medtronic Cardiac Rhythm and Heart Failure; Industry
Eligibility: 18 Years and older
Enrollment: 3,032 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2010
U.S. locations: 113
States / cities: Tucson, Arizona • Little Rock, Arkansas • Fresno, California + 107 more

Conditions: Heart Failure, Ventricular Arrythmias
Interventions: Testing of the autocapture features of the device; Device
Lead sponsor: Abbott Medical Devices; Industry
Eligibility: 18 Years and older
Enrollment: 128 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 5
States / cities: Little Rock, Arkansas • Browns Mills, New Jersey • Nashville, Tennessee + 1 more

Conditions: Heart Failure, Systolic
Interventions: Not listed
Lead sponsor: Todd M Koelling, MD; Other
Eligibility: 18 Years and older
Enrollment: 452 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Chronic Heart Failure
Interventions: BAY2413555 Dose 1, BAY2413555 Dose 2, Placebo to BAY2413555; Drug
Lead sponsor: Bayer; Industry
Eligibility: 18 Years to 79 Years
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 3
States / cities: Atlanta, Georgia • Silver Spring, Maryland • Camp Hill, Pennsylvania

Conditions: Heart Disease
Interventions: ICD (Implantable Cardioverter Defibrillator); Device
Lead sponsor: Medtronic Cardiac Rhythm and Heart Failure; Industry
Eligibility: 18 Years and older
Enrollment: 1,031 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2008
U.S. locations: 50
States / cities: Anchorage, Alaska • Little Rock, Arkansas • North Little Rock, Arkansas + 47 more

Conditions: Implantable Cardioverter-defibrillators (ICDs)
Interventions: Pre-visit timing of receipt of the ICDs implantation decision aid, Post-visit timing of receipt of the ICDs implantation decision aid; Behavioral
Lead sponsor: Emory University; Other
Eligibility: 18 Years and older
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019
U.S. locations: 3
States / cities: Atlanta, Georgia

Conditions: Need for MRI Imaging With Pacemaker or, Implantable Cardioverter Defibrillator Implanted
Interventions: MRI with pacemaker or ICD; Device
Lead sponsor: Scripps Health; Other
Eligibility: 18 Years and older
Enrollment: 2,039 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2014
U.S. locations: 21
States / cities: Burbank, California • La Jolla, California • Los Angeles, California + 16 more

Conditions: Atrial Fibrillation, Heart Failure
Interventions: FDA approved rate and rhythm control drugs, AV Node ablation and device implant; Drug · Device
Lead sponsor: Mayo Clinic; Other
Eligibility: 65 Years and older
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2011
U.S. locations: 5
States / cities: Scottsdale, Arizona • Evansville, Indiana • Rochester, Minnesota + 2 more

Search by objective public record fields.

Randomized Study of the Use of Warfarin During Pacemaker or ICD Implantation in Patients Requiring Long Term Anticoagulation

Efficacy of Implantable Defibrillator Therapy After a Myocardial Infarction

PRE-DETERMINE Cohort Study

Utility of the Audible Alert in Current Generation Medtronic Implantable Cardioverter-defibrillators

Substrate Targeted Ablation Using the FlexAbility™ Ablation Catheter System for the Reduction of Ventricular Tachycardia

The Registry Evaluating Functional Outcomes of Resynchronization Management

Implantable Cardioverter Defibrillator (ICD) Function During Ventricular Assist Device (VAD) Implantation

Air Pollution and Implantable Cardioverter Defibrillators

Understanding Outcomes With the EMBLEM™ S-ICD in Primary Prevention Patients With Low Ejection Fraction

MANAGE-VT Registry - MANAGEment of Ventricular Tachycardia Outcomes Registry

Trial to Determine Imaging Parameters of LMI1195 in Heart Failure Patients at Low and High Risk of Defibrillator Firing

LONGEVITY Study. Evaluation of the Device and Battery Longevity of Boston Scientific Market-released ICD and CRT-D Devices

iBeat Wristwatch Validation Study

Remote Device Interrogation In The Emergency Department

The Efficacy of Single Coil Defibrillation Leads for Internal Cardioversion of Atrial Fibrillation

Heart Failure Optimization Study

OMNI Study--Assessing Therapies in Medtronic Pacemaker, Defibrillator, and Cardiac Resynchronization Therapy Devices.

Safety and Efficacy of Automatic Testing Feature in New ICDs and CRT-Ds

Patient and Physician Survey Determinants of Appropriate ICD Utilization

A Study to Learn How Safe Study Drug BAY2413555 is, How it Affects the Body, and How it Moves Into, Through, and Out of the Body Over 4 Weeks of Use in Participants With Heart Failure and Implanted Cardiac Defibrillator or Cardiac Resynchronization Devices (ICD/CRT)

Managed Ventricular Pacing ("MVP") Trial

Syngery-Evaluating the Impact of Decision Aid

The MagnaSafe Registry: Determining the Risks of Magnetic Resonance Imaging (MRI) in the Presence of Pacemakers and Implantable Cardioverter Defibrillators (ICDs)

AV Node Ablation and Pacemaker Therapy Compared to Drug Therapy for Atrial Fibrillation - Pilot Study